GSK and Alector collaborate on Alzheimer’s and Parkinson’s treatments
Fortune - 02-Jul-2021The $2.2 billion deal will focus on immune-based therapies for neurodegenerative diseases
Join the club for FREE to access the whole archive and other member benefits.
Author at Financial Times
Suzi Ring is a prominent legal correspondent for the Financial Times based in London. She covers topics such as white-collar crime, antitrust issues, and the business of law, and also co-writes the FT's "Full Disclosure" newsletter. Prior to joining FT, Suzi spent a decade at Bloomberg News, where she reported on healthcare, Brexit, and legal affairs. Her work often sheds light on significant regulatory matters and corporate legal issues
Visit website: https://fortune.com/author/suzi-ring/
See also: Financial Times (FT) - News provider covering business and economic current affairs
Details last updated 16-Nov-2024
The $2.2 billion deal will focus on immune-based therapies for neurodegenerative diseases